Aging Research Headlines
Q & A with Buck Institute Expert Judith Campisi
We continue our Healthspan Campaign Expert Q & A series with Judith Campisi, Ph.D., from the Buck Institute for Research on Aging. She talks about her cutting-edge research into cellular senescence and the evolution of her career as a researcher. She also shares on how "advances in research are changing the way we all look at many old ideas." Learn more about this gifted researcher.
Article Summarizes Biomedical Approaches for Extension of Healthspan
Extension of healthspan on a global scale is of utmost importance as the world population lives longer than ever before. This article published in The Journals of Gerontology outlines the biomedical approaches and action items that its authors—many of whom are affiliated with the Healthspan Campaign—believe represent the best opportunity for this goal to be realized.
Upcoming National Geographic Channel Special on 'The Age of Aging'/November 29
You'll want to mark your calendars for November 29 at 9 p.m. ET as the National Geographic Channel will debut a special feature called "The Age of Aging" as part of its Breakthrough series. The special will include interviews with healthspan experts such as Steven Austad, Ph.D., Nir Barzilai, M.D., and James Kirkland, M.D., Ph.D. You can find out more here. Also, look for our interview with Dr. Austad in next month's issue to learn more about the special.
International Day of Older Persons Wrap Up
The world celebrated International Day of Older Persons on October 1. Healthspan Campaign partner, the International Society on Aging and Disease (ISOAD), led a global campaign to emphasize the importance of aging and longevity research for the development of effective health care for older adults. ISOAD’s efforts resulted in events being held in more than 40 countries around the globe. Learn more about this campaign and read own thoughts on the day.
World Health Organization Releases Report on Aging and Health
A new report released by the World Health Organization brings the issues of aging and health into critical focus. It notes that although people are living longer due to advances in medicine changes will need to be made to ensure these years are lived in good health. “Today, most people, even in the poorest countries, are living longer lives,” says Dr. Margaret Chan, director-general of WHO. “But this is not enough. We need to ensure these extra years are healthy, meaningful and dignified. Achieving this will not just be good for older people, it will be good for society as a whole.” Read the report here.
Leading Experts Present at SENS Foundation's Rejuvenation Biotechnology Conference
On August 19-21, hundreds of experts came together in San Francisco to take part in the second annual Rejuvenation Biotechnology Conference, "a forum for thought leaders from multiple disease communities to consider the wider potential of novel strategies for early intervention, while evaluating the feasibility of preventive and combinatorial medicine applications to treat all aging-related diseases." The conference was highlighted by two keynote speeches from Chas Bountra, Ph.D., from Oxford University on "Transforming the Discovery of New Medicines" and Frances Colon, Ph.D., from the U.S. Department of State on "Science and Technology for Diplomacy."
Gerontological Society of America's Annual Scientific Meeting, Orlando, FL, November 18-22, 2015GSA's 68th Annual Scientific Meeting brings together more than 4,000 of the brightest minds in the field of aging. This meeting is the premier gathering of gerontologists from both the United States and around the world. They participate in over 450 scientific sessions including symposia, paper, and poster presentations. The 2015 theme is “Aging as a Lifelong Process,” which highlights the fact that what gerontologists study is actually the cumulative outcome of lifelong events that culminate during old age. These effects, which can begin at the earliest stage of fetal development, encompass biology, social interactions, historical events, psychological experiences, and public policy. Importantly, the life-course effects on aging are best viewed through the interdisciplinary lens that is the signature feature of GSA. For more information, go here.
2016 International Conference on Sarcopenia and Frailty Research, Philadelphia, PA, April 28-29
International Conference on Aging and Disease (ICAD), Stanford University, October 1-2, 2016The International Society on Aging and Disease's 2016 ICAD Conference is one of the leading international conferences for presenting novel and fundamental advances in the fields of aging and age-related disease. The purpose of the conference is for the scientists, scholars, and students from the universities and the research institutes all around the world to present ongoing research activities and hence to foster research relations. This conference provides opportunities for the delegates to exchange new ideas and application experiences face-to- face, to establish research or business relations, and to find global partners for future collaboration. It also serves to foster communication among researchers and practitioners working in a wide variety of scientific areas with a common interest in fighting aging and age-related disease. For more information, please go here.
Progeria Research Foundation Seeks Proposals for Research on Hutchinson-Gilford Progeria Syndrome (HGPS, or Progeria)
The Progeria Research Foundation has sent out a call for proposals for research on Hutchinson-Gilford Progeria Syndrome. PRF encourages proposals in the areas listed below. Investigators are not limited to applications that address these priorities, but rather are encouraged to use them to better understand the needs of the field at this time.
PRF is seeking proposals that address the following priorities:
Discovery of biological markers of disease in HGPS that can be assessed in human and/or mouse samples. Highest priority will be given to those markers that can be assayed in easily obtainable human samples such as blood, urine, and cheek swabs. In addition, proposals that explore biomarker relevance to disease process and/or change in markers with disease treatment are encouraged.
Discovery and/or testing of candidate treatment compounds in both cell based and mouse models of HGPS. Of note, proposals should test compounds in a progerin-producing mouse model as the priority. Comparisons to other mouse models of disease, such as ZMPSTE24 -/- and other non-progerin producing mouse models, is acceptable, but only as a comparison to progerin-producing models.